AzTrials
AzTrials

Proximal Humeral FracturePHF-DNCT05735561

Proximal Humerus Fracture Dislocation Direction and Avascular Necrosis

An observational study of Proximal Humeral Fracture and Dislocation, run by Fraser Orthopaedic Research Society at 1 site in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of the study is to see if there is a connection between a proximal humerus fracture dislocation direction and the likelihood of developing avascular necrosis. Utilizing a retrospective cohort from the last ten years we hope to bring consenting patients back for a single visit to have x-rays and complete… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
X-Ray
How many people
25 participants
Where
1 siteCanada
Study dates
15 Feb 2023to 31 Aug 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Skeletally mature patients who were surgically treated for their proximal humerus fracture dislocation between 2011 and 2021.

Who may be able to join

  • Patients 18 years of age or older
  • Patients who underwent operative fixation of proximal humerus fracture dislocation at Royal Columbian Hospital between January 2011 and July 2021
  • Willing and able to consent and complete patient reported outcome measures
  • Willing and able to follow the protocol and attend a follow-up visit
  • Able to read and understand English or have an interpreter available

Who cannot join

  • Skeletally immature patients
  • Patient with pathological fractures
  • Patients who have had previous operative fixation of proximal humerus
  • Patients treated non-operatively
  • patients presenting outside of the study duration window
  • Patients treated by a non-participating surgeon
Show all 11Show fewer
  • Deceased patients
  • Patients unable to complete patient reported outcome measures
  • Patients declining to come back to the clinic for updated x-rays
  • Dementia
  • Incarceration

Trial locations and contacts

1 site in 1 country.

Canada1 site
  • Royal Columbian Hospital/Fraser Health Authority

    New Westminster, British Columbia, V3L 3W7

Other trials in Canada

About this study

Official title: Association Between the Direction of Proximal Humerus Fracture Dislocation and Risk of Avascular Necrosis Following Open Reduction Internal Fixation - An Observational, Cohort Study

The purpose of the study is to see if there is a connection between a proximal humerus fracture dislocation direction and the likelihood of developing avascular necrosis. Utilizing a retrospective cohort from the last ten years we hope to bring consenting patients back for a single visit to have x-rays and complete patient reported outcome measures to assess for evidence of avascular necrosis.

Read the detailed description

The incidence of proximal humerus fractures continues to increase and is among one of the more common fractures seen in the adult population. Proximal humerus fracture dislocations, however, are less common. Despite the decreased prevalence, fracture dislocations have unique challenges with respect to obtaining an anatomical reduction and more frequently involve an open surgical reduction. In addition, depending on other fracture characteristics, there are various treatment options for the fracture itself. While fracture dislocations ultimately lead to increased AVN and revision surgery, further discussion surrounding the direction of dislocation and how it may influence overall outcomes has not been addressed in the previous literature. The study design utilizes a retrospective cohort from the last ten years, by asking patients who have had a previously surgically treated proximal humerus fracture dislocations to come back to the surgeon's private clinic to complete a single visit assessment. During this assessment the consenting participant will receive x-rays and complete patient reported outcome measures. In conjunction, these will be utilized to assess overall function and the existence of avascular necrosis.

Being tested
X-Ray
Medical subject headings
Shoulder Fractures, Joint Dislocations, Shoulder Dislocation, Osteonecrosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • X-RayDiagnostic test

    Consenting participants will be asked to come into the clinic for a single visit, during this visit they will be asked to complete an x-ray to check for evidence of avascular necrosis.

Study groups in NCT05735561
Study groupRoleWhat they receive
Proximal Humerus Fracture Anterior DislocationThe study doesn't provide any intervention. This group is defined as having a dislocation that is anterior to the glenoid.
Proximal Humerus Fracture Posterior DislocationThe study doesn't provide any intervention. This group is defined as having a dislocation that is posterior to the glenoid.
Receives: Diagnostic Test: X-Ray
Proximal Humerus Fracture Varus DislocationThe study doesn't provide any intervention. This group is defined as having a dislocation that is in varus compared to the glenoid.
Receives: Diagnostic Test: X-Ray
Proximal Humerus Fracture Valgus DislocationThe study doesn't provide any intervention. This group is defined as having a dislocation that is in valgus compared to the gelnoid.
Receives: Diagnostic Test: X-Ray

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rates of Avascular Necrosis

    The presence and advancement of avascular necrosis (as classified by the Cruess Classification System) and as assessed on radiographs.

    Measured: At least 2 years post fracture fixation

  2. Direction of the Humeral Fracture Dislocation

    As characterized by the direction of the humeral head in relation to the glenoid, based on AP, Lateral, or Axillary x-ray views.

    Measured: At least 2 years post fracture fixation

Secondary outcomes (2)
  1. DASH (functional outcome)

    Asking participants to complete the Disabilities of the Arm, Shoulder, and Hand outcome measure as a way of assessing function.

    Measured: At least 2 years post fracture fixation

  2. Constant Score (functional outcome)

    Asking participants to complete the Constant Score patient reported outcome measure as a way of assessing participant function.

    Measured: At least 2 years post fracture fixation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Feb 2023
  2. Study start15 Feb 2023
  3. Primary completion31 Jul 2023
  4. Study completion31 Aug 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
25 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05735561
Sponsor's protocol ID
2023-006
Acronym
PHF-D
Status last verified
Sep 2023
First submitted
27 Jan 2023
Last updated
13 Sep 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There is currently no plan to share individual participant data with other researchers, results will of course be shared. However, the hope is that the study might indicate a need for a high powered prospective clinical trial to be completed.

Publications

  • Schumaier A, Grawe B. Proximal Humerus Fractures: Evaluation and Management in the Elderly Patient. Geriatr Orthop Surg Rehabil. 2018 Jan 25;9:2151458517750516. doi: 10.1177/2151458517750516. eCollection 2018.

    PubMed 29399372
  • Greiner S, Kaab MJ, Haas NP, Bail HJ. Humeral head necrosis rate at mid-term follow-up after open reduction and angular stable plate fixation for proximal humeral fractures. Injury. 2009 Feb;40(2):186-91. doi: 10.1016/j.injury.2008.05.030. Epub 2008 Dec 18.

    PubMed 19100544
  • Hertel R, Hempfing A, Stiehler M, Leunig M. Predictors of humeral head ischemia after intracapsular fracture of the proximal humerus. J Shoulder Elbow Surg. 2004 Jul-Aug;13(4):427-33. doi: 10.1016/j.jse.2004.01.034.

    PubMed 15220884
  • Boesmueller S, Wech M, Gregori M, Domaszewski F, Bukaty A, Fialka C, Albrecht C. Risk factors for humeral head necrosis and non-union after plating in proximal humeral fractures. Injury. 2016 Feb;47(2):350-5. doi: 10.1016/j.injury.2015.10.001. Epub 2015 Oct 22.

    PubMed 26706457
  • Miltenberg B, Masood R, Katsiaunis A, Moverman MA, Puzzitiello RN, Pagani NR, Menendez ME, Salzler MJ, Drager J. Fracture dislocations of the proximal humerus treated with open reduction and internal fixation: a systematic review. J Shoulder Elbow Surg. 2022 Oct;31(10):e480-e489. doi: 10.1016/j.jse.2022.04.018. Epub 2022 May 20.

    PubMed 35605847
  • Cruess RL, Blennerhassett J, MacDonald FR, MacLean LD, Dossetor J. Aseptic necrosis following renal transplantation. J Bone Joint Surg Am. 1968 Dec;50(8):1577-90. No abstract available.

    PubMed 4881164

Questions about this trial

What is this clinical trial studying?

An observational study of Proximal Humeral Fracture and Dislocation, run by Fraser Orthopaedic Research Society at 1 site in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Sep 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rates of Avascular Necrosis (time frame: At least 2 years post fracture fixation). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05735561, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Sep 2023; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in